BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 3008601)

  • 1. Safety of a temperature-sensitive vaccine strain of bovine viral diarrhea virus in pregnant cows.
    Lobmann M; Charlier P; Klaassen CL; Zygraich N
    Am J Vet Res; 1986 Mar; 47(3):557-60. PubMed ID: 3008601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of a temperature-sensitive bovine viral diarrhea vaccine strain.
    Lobmann M; Charlier P; Florent G; Zygraich N
    Am J Vet Res; 1984 Dec; 45(12):2498-503. PubMed ID: 6098205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral and viral protein specificity of antibodies induced in cows persistently infected with noncytopathic bovine viral diarrhea virus after vaccination with cytopathic bovine viral diarrhea virus.
    Bolin SR
    Am J Vet Res; 1988 Jul; 49(7):1040-4. PubMed ID: 2844105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic detection and practical consequences of antigenic diversity among bovine viral diarrhea viruses in a vaccinated herd.
    Bolin SR; Littledike ET; Ridpath JF
    Am J Vet Res; 1991 Jul; 52(7):1033-7. PubMed ID: 1654030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bovine viral diarrhea virus on conception in cattle.
    Whitmore HL; Zemjanis R; Olson J
    J Am Vet Med Assoc; 1981 May; 178(10):1065-7. PubMed ID: 6268584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of cattle persistently infected with noncytopathic bovine viral diarrhea virus to vaccination for bovine viral diarrhea and to subsequent challenge exposure with cytopathic bovine viral diarrhea virus.
    Bolin SR; McClurkin AW; Cutlip RC; Coria MF
    Am J Vet Res; 1985 Dec; 46(12):2467-70. PubMed ID: 3002214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of viral components of a nonabortigenic combination vaccine for prevention of respiratory and reproductive system diseases in cattle.
    Talens LT; Beckenhauer WH; Thurber ET; Cooley AJ; Schultz RD
    J Am Vet Med Assoc; 1989 May; 194(9):1273-80. PubMed ID: 2542202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a bovine virus diarrhea vaccine.
    Chapek ML; McClaughry LE; Wilkins LM
    Mod Vet Pract; 1978 Oct; 59(10):755-7. PubMed ID: 216898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine viral diarrhea virus infection in captive exotic ruminants.
    Doyle LG; Heuschele WP
    J Am Vet Med Assoc; 1983 Dec; 183(11):1257-9. PubMed ID: 6315662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of a combined parapox/BVD vaccine.
    Büttner M
    Dev Biol Stand; 1986; 65():221-6. PubMed ID: 3030862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
    Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
    Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity and duration of neutralizing antibodies induced in healthy cattle after administration of a modified-live virus vaccine against bovine viral diarrhea.
    Cortese VS; Whittaker R; Ellis J; Ridpath JF; Bolin SR
    Am J Vet Res; 1998 Jul; 59(7):848-50. PubMed ID: 9659549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on transplacental transmissibility of a bovine virus diarrhoea (BVD) vaccine virus in cattle. II. Inoculation of pregnant cows without detectable neutralizing antibodies to BVD virus 90-229 days before parturition (51st to 190th day of gestation).
    Liess B; Orban S; Frey HR; Trautwein G; Wiefel W; Blindow H
    Zentralbl Veterinarmed B; 1984 Oct; 31(9):669-81. PubMed ID: 6097070
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
    Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
    Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of persistent bovine viral diarrhea virus infection in selected cattle herds.
    Bolin SR; McClurkin AW; Coria MF
    Am J Vet Res; 1985 Nov; 46(11):2385-7. PubMed ID: 3000232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive performance of apparently healthy cattle persistently infected with bovine viral diarrhea virus.
    McClurkin AW; Coria MF; Cutlip RC
    J Am Vet Med Assoc; 1979 May; 174(10):1116-9. PubMed ID: 220208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against mucosal disease--bovine viral Diarrhea (MD-BVD) in calves applying lapinized vaccine against swine fever and a modified live virus of MD-BVD.
    Haralambiev H; Tsvetkov P; Nikolov A; Gaytandgieva R
    Arch Exp Veterinarmed; 1975; 29(5):701-4. PubMed ID: 180923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.